Hancock Jaffe Laboratories Inc Institutional ownership
What is the Institutional ownership of Hancock Jaffe Laboratories Inc?
The Institutional ownership of Hancock Jaffe Laboratories Inc is 21.37%
What is the definition of Institutional ownership?
Institutional Ownership is the amount of a company’s available stock owned by mutual or pension funds, insurance companies, investment firms, endowments or other large entities that manage funds on the behalf of others.
Given the considerable sums of money that institutions invest, it is not surprising that they tend to be much more knowledgeable than the average investor when it comes to the companies and industries in which they have invested.
Institutional portfolio managers often meet personally with a company's top executives, and in many cases the research they conduct is further supported by equity analysts who evaluate prospective companies and industries in great depth before making specific investment recommendations.
Institutional ownership of companies in the Health Care sector on NASDAQ compared to Hancock Jaffe Laboratories Inc
What does Hancock Jaffe Laboratories Inc do?
Hancock Jaffe Laboratories specializes in developing and manufacturing bioprosthetic (tissue-based) medical devices to establish improved standards of care for treating cardiac and vascular diseases. HJLI currently has two lead product candidates: the VenoValveÒ, a porcine-based valve which is intended to be surgically implanted in the deep venous system of the leg to treat reflux associated with Chronic Venous Insufficiency, and the CoreoGraftÒ, a bovine tissue-based off-the-shelf conduit intended to be used for coronary artery bypass surgery.
Companies with institutional ownership similar to Hancock Jaffe Laboratories Inc
- Cherry Hill Mortgage Investment has Institutional ownership of 21.33%
- Salt Lake Potash has Institutional ownership of 21.34%
- Cyclopharm has Institutional ownership of 21.36%
- Compass Diversified has Institutional ownership of 21.36%
- NeuroOne Medical Technologies has Institutional ownership of 21.36%
- Allied Esports Entertainment has Institutional ownership of 21.36%
- Hancock Jaffe Laboratories Inc has Institutional ownership of 21.37%
- Sharda Cropchem has Institutional ownership of 21.39%
- Cellectis SA has Institutional ownership of 21.39%
- eve Sleep plc has Institutional ownership of 21.39%
- Crown Resorts has Institutional ownership of 21.39%
- Texwinca has Institutional ownership of 21.39%
- CareRx has Institutional ownership of 21.40%